Presence of tetrahydroisoquinoline-related compounds, possible MPTP-like neurotoxins, in parkinsonian brain.
Niwa
T
T
Department of Internal Medicine, Nagoya University Branch Hospital, Japan.
Takeda
N
N
Yoshizumi
H
H
Tatematsu
A
A
Yoshida
M
M
Dostert
P
P
Naoi
M
M
Nagatsu
T
T
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000493:pharmacokinetics*; D001711:Biotransformation; D046508:Culture Techniques; D004298:Dopamine / Q000378:metabolism; D005625:Frontal Lobe / Q000473:pathology*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007546:Isoquinolines / Q000493:pharmacokinetics*; D009498:Neurotoxins / Q000493:pharmacokinetics*; D010300:Parkinson Disease / Q000473:pathology*; D013329:Structure-Activity Relationship; D044005:Tetrahydroisoquinolines
D007546:Isoquinolines; D009498:Neurotoxins; D044005:Tetrahydroisoquinolines; C069194:2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline; C050386:1-methyl-1,2,3,4-tetrahydroisoquinoline; C036617:salsolinol; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine